Cargando…

A clinical profile of patients with Parkinson's disease and psychosis

AIMS: The aim of the study was to study the clinical profile of the patients with Parkinson's disease (PD) and psychosis. SETTINGS AND DESIGN: This was a prospective, cross sectional, hospital-based study done at the Department of Neurology, National Institute of Mental Health and Neurosciences...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amar, B. R., Yadav, Ravi, Janardhan Reddy, Y. C., Pal, Pramod Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090845/ https://www.ncbi.nlm.nih.gov/pubmed/25024570 http://dx.doi.org/10.4103/0972-2327.132625

Ejemplares similares

Neuropsychological profile in early Parkinson's disease: Comparison between patients with right side onset versus left side onset of motor symptoms
por: Adwani, Sikandar, et al.
Publicado: (2016)

Comparison of Pre-Deep Brain Stimulation Clinical Profiles of Patients with Young and Late-Onset Parkinson's Disease
por: Muthukumaran, P, et al.
Publicado: (2022)

Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker
por: Ramaswamy, Palaniswamy, et al.
Publicado: (2020)

Research in Parkinson's disease in India: A review
por: Surathi, Pratibha, et al.
Publicado: (2016)

Abnormal Subcortical Volumes and Cortical Thickness in Parkinson's Disease with Impulse Control Disorders
por: Prasad, Shweta, et al.
Publicado: (2019)

Motor Speed Matters! Cognitive Profile of Parkinson’s Disease Patients With and Without Deficits in Motor Speed
por: Menon, Vidya, et al.
Publicado: (2021)

Disability Certification for Parkinson’s Disease in India: Challenges and the Way Forward
por: Arun, M, et al.
Publicado: (2023)

Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
por: Vandana, Valiyaparambath Purushothaman, et al.
Publicado: (2021)

Deficits in Emotion Perception and Cognition in Patients with Parkinson's Disease: A Systematic Review
por: Gothwal, Mohit, et al.
Publicado: (2022)

A multicentre study on grey matter morphometric biomarkers for classifying early schizophrenia and parkinson’s disease psychosis
por: Knolle, Franziska, et al.
Publicado: (2023)

Can Circulating microRNAs Identify Sudden Unexpected Death in Parkinson's Disease ?
por: Ramaswamy, Palaniswamy, et al.
Publicado: (2021)

Clinical and Imaging Profile of Patients with Joubert Syndrome
por: Surisetti, Bharath Kumar, et al.
Publicado: (2021)

Erratum: Speech Characteristics of Patients with Parkinson's Disease–Does Dopaminergic Medications Have a Role?
por: Vandana, Valiyaparambath Purushothaman, et al.
Publicado: (2022)

Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
por: Goyal, Sheetal, et al.
Publicado: (2022)

Parkinson's Disease and Wearable Technology: An Indian Perspective
por: Bagrodia, Vaishali, et al.
Publicado: (2022)

NIMHANS Neuropsychological Battery for Elderly in Parkinson’s Disease Patients: Validation and Diagnosis using MDS PD-MCI Task Force Criteria in Indian Population
por: Botta, Ragasudha, et al.
Publicado: (2023)

Psychosis in Parkinson's disease
Publicado: (2011)

A Comparative Study of Early and Late Onset Freezing of Gait in Parkinson’s Disease
por: Prasad, Shweta, et al.
Publicado: (2018)

Alterations in Polysomnographic (PSG) profile in drug-naïve Parkinson's disease
por: Joy, Sanju P., et al.
Publicado: (2014)

Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges
por: Waddington, John L.
Publicado: (2020)

Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice
por: Dashtipour, Khashayar, et al.
Publicado: (2021)

A Study of Battery Replacement Characteristics of Patients With Parkinson’s Disease and Factors Influencing Battery Drain
por: Sharma, Praveen, et al.
Publicado: (2023)

Parkinson Disease Psychosis: Update
por: Friedman, J. H.
Publicado: (2013)

Knowledge, Attitude, and Perceptions about Deep Brain Stimulation for Parkinson’s Disease: Observations from a Single Indian Center
por: Prasad, Shweta, et al.
Publicado: (2021)

Pimavanserin in Parkinson’s Disease-induced Psychosis: A Literature Review
por: Patel, Rikinkumar S, et al.
Publicado: (2019)

Clinical neurophysiology of Parkinson’s disease and parkinsonism
por: Chen, Robert, et al.
Publicado: (2022)

Morphometric mapping of the macrostructural abnormalities of midsagittal corpus callosum in Wilson’s disease
por: Stezin, Albert, et al.
Publicado: (2021)

Psychosis in Parkinson’s disease: a clinical biomarker of disease stage and prognosis
por: Pinho, M., et al.
Publicado: (2023)

The experience of care partners of patients with Parkinson’s disease psychosis
por: Mantri, Sneha, et al.
Publicado: (2021)

Why psychosis is frequently associated with Parkinson's disease?
por: Zhong, Jingmei, et al.
Publicado: (2013)

Clinical, Radiological, and Genetic Profile of Spinocerebellar Ataxia 12: A Hospital-Based Cohort Analysis
por: Ganaraja, Valakunja Harikrishna, et al.
Publicado: (2022)

Bifrontal ECT for drug-induced psychosis in Parkinson's disease
por: Muralidharan, K., et al.
Publicado: (2011)

A novel scale to assess psychosis in patients with parkinson's disease
por: Ondo, William G., et al.
Publicado: (2015)

Increased risk of falls and fractures in patients with psychosis and Parkinson disease
por: Forns, Joan, et al.
Publicado: (2021)

Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
por: Oehrn, Carina R., et al.
Publicado: (2021)

Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis
por: Tampi, Rajesh R, et al.
Publicado: (2019)

Cortical and Striatal Reward Processing in Parkinson’s Disease Psychosis
por: Garofalo, Sara, et al.
Publicado: (2017)

Psychosis Assessment in Early-Stage Parkinson's Disease: Comparing Parkinson's Psychosis Questionnaire with the Brief Psychiatric Rating Scale in a Portuguese Sample
por: Cargaleiro, I., et al.
Publicado: (2012)

Pimavanserin (Nuplazid™) for the treatment of Parkinson disease psychosis: A review of the literature
por: Touma, Katie T. B., et al.
Publicado: (2018)

Psychosis in parkinsonism: an unorthodox approach
por: Onofrj, Marco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gds2efgmue8rn30hu6cmmatcth